ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.
rosuvastatin "accord" 10 mg filmovertrukne tabletter
accord healthcare b.v. - rosuvastatin calcium - filmovertrukne tabletter - 10 mg
rosuvastatin "accord" 20 mg filmovertrukne tabletter
accord healthcare b.v. - rosuvastatin calcium - filmovertrukne tabletter - 20 mg
rosuvastatin "accord" 40 mg filmovertrukne tabletter
accord healthcare b.v. - rosuvastatin calcium - filmovertrukne tabletter - 40 mg
rosuvastatin "accord" 5 mg filmovertrukne tabletter
accord healthcare b.v. - rosuvastatin calcium - filmovertrukne tabletter - 5 mg
tolak 40 mg/g creme
medartuum ab - fluoruracil - creme - 40 mg/g
nitoman 25 mg tabletter
medilink a/s - tetrabenazin - tabletter - 25 mg
clariscan 279,3 mg/ml injektionsvæske, opløsning
ge healthcare as - gadoterinsyre - injektionsvæske, opløsning - 279,3 mg/ml
gemstada 38 mg/ml koncentrat til infusionsvæske, opløsning
stada arzneimittel ag - gemcitabinhydrochlorid - koncentrat til infusionsvæske, opløsning - 38 mg/ml
terbinafin "orifarm" 250 mg tabletter
orifarm generics a/s - terbinafinhydrochlorid - tabletter - 250 mg